1,4-benzothiazine

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

1.	Keshari, Amit K: 2 articles (01/2018 - 01/2017)
2.	Rai, Amit: 2 articles (01/2018 - 01/2017)
3.	Raj, Vinit: 2 articles (01/2018 - 01/2017)
4.	Saha, Sudipta: 2 articles (01/2018 - 01/2017)
5.	Singh, Ashok K: 2 articles (01/2018 - 01/2017)
6.	Chand, Gyan: 1 article (01/2018)
7.	De, Arnab: 1 article (01/2018)
8.	Gosipatala, Sunil Babu: 1 article (01/2018)
9.	Kumar, Dinesh: 1 article (01/2018)
10.	Kumar, Pranesh: 1 article (01/2018)

1.	Colonic Neoplasms (Colon Cancer) 01/01/2017 - "In this study, common pharmacophore models and atom-based 3D-QSAR studies were carried out by using 1,4-benzothiazine derivatives with their experiential GI50values towards HT-29 human colon cancer cell line. " 01/01/2018 - "As per this scenario, we recently prepared and tested novel 1,4-benzothiazine derivatives against HT-29 human colon cancer cell line. "
2.	Atherosclerosis 01/01/2017 - "Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis."
3.	Candidiasis (Moniliasis) 11/01/2002 - "We have recently described the synthesis and antifungal activity of a series of 1,4-benzothiazine and 1,4-benzoxazine imidazole derivatives that mainly showed in vivo activity against a murine experimental model of candidiasis but that very often lacked in vitro activity. "